Global Trichomonas Rapid Testing Market 2022 - Feasibly Instrumenting the Early Diagnosis of Trichomoniasis

Persistence Market Research published a report on the trichomonas rapid testing market, which considers the global industry analysis 2014 - 2018 and opportunity assessment 2019-2029, and projects that the trichomonas rapid testing market is expected to reach ~ US$ 360 Mn by the end of 2019 in terms of value, and is forecasted to reach ~ US$ 590 Mn by the end of 2029.

Request For Free Sample Report of "Trichomonas Rapid Testing Market"@ https://www.persistencemarketresearch.com/samples/19603

Rising Prevalence of Trichomoniasis Infection

In a report by World Health Organization, it is stated that the worldwide annual incidence rate of trichomoniasis is over 170 million cases. The prevalence of trichomonas infection is highest among other STDs such as Chlamydia trachomatis and Neisseria gonorrhoeae. According to the Centers for Disease Control and Prevention (CDC), at any given time, 3.7 million people are infected in Americas only, and one million new cases are estimated each year. Many studies evaluate that the prevalence of trichomonas infection affects more than 11% of women aged between 40 to 49 years. Therefore, the rise in patient pool suffering from trichomonas infection throughout the globe will upsurge the growth of the trichomonas rapid testing market.

Availability of Broad Options for Diagnosis Anticipated to Drive the Market Growth

Innovation and advancements in the diagnostics industry, especially in the diagnosis of sexually transmitted infections like trichomoniasis that are hard to detect, have resulted in the availability of wide range of products in the market for trichomonas rapid testing. In the current scenario, the options that are available in the market for trichomonas rapid testing usually come in the form of strips, swabs, cassettes, and assay kits. Evolution and improvements in trichomonas rapid testing avenues have also led to the development of point-of-care and self-test methods. As an added value to the time and money spent by hospitals, clinics, and other end users, these trichomonas rapid testing kits have shown sensitivity and specificity rates that coincide with that of gold-standard testing methods. Thus, advancements in trichomonas rapid testing kits are likely to boost the revenue generation of the trichomonas rapid testing market.

Companies

Sekisui Diagnostics (Sekisui Chemical)
Cepheid
Quidel Corporation
Becton, Dickinson and Company
Hologic, Inc.
Creative Diagnostics
Koroglu Medical Devices
Nal Von Minden GmbH
Common Sense
Jei Daniel Biotech Corp
Nanjing Liming Bio-products Co., Ltd

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/19603

High Risk of HIV and Other Serious Infections Elevating Demand

Recent developments in research over trichomoniasis with the availability of trichomonas rapid testing kits have determined that once an over-looked infection, trichomoniasis now has been associated with many serious health threats, especially in women. Many studies done over a number of groups of high-risk population have shown strong evidence that trichomonas vaginalis increases both transmission and acquisition of HIV, the causative agent of AIDS, among women. Additionally, in affected pregnant women, trichomoniasis infection has been noticed to be the cause of premature delivery and low birth weight of babies. According to CDC, the reoccurrence rate of the infection in women can be as high as 17 percent even after three months of treatment. Use of trichomonas rapid testing kits is recommended by doctors time-to-time to detect the infection. All these factors are likely to elevate the market growth for trichomonas rapid testing even further.

Key Players in Trichomonas Rapid Testing Market

Some key players in the global trichomonas rapid testing market include Cepheid, Quidel Corporation, Becton, Dickinson and Company (BD), Hologic Inc., Sekisui chemical co. ltd (Sekisui Diagnostics), Creative Diagnostics, Nal Von Minden GmbH, Common Sense Ltd., Jei Daniel Biotech Corp., Nanjing Liming Bio-products Co., Ltd, Koroglu Medical Devices, and others.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/19603

Key Questions Answered in This Report.

What are the Roadblocks for Trichomonas Rapid Testing Market Suppliers?
What are the Key Opportunities for Trichomonas Rapid Testing Market Manufacturers?
How is Focus on Safety Influencing Trichomonas Rapid Testing Market Demand?
What is the Regulatory Impact on Global Sales of Trichomonas Rapid Testing Market?
Which Region Offers the Largest Opportunity for Sales of Trichomonas Rapid Testing Market?
Where Does the U.S. Stand in the Market for Trichomonas Rapid Testing Market?
What Is the Outlook for Trichomonas Rapid Testing Market Manufacturers in China?
Why is Germany a Lucrative Market for Trichomonas Rapid Testing Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Trichomonas Rapid Testing Market?
Why is There High Demand for Tires in Trichomonas Rapid Testing Market?
Why are Sales of Trichomonas Rapid Testing Market Surging?

For More Premium Insights, Check out the Link:

Systemic Scleroderma Treatment Market - https://www.persistencemarketresearch.com/market-research/systemic-scleroderma-treatment-market.asp

Primary Hepatocytes Market - https://www.persistencemarketresearch.com/market-research/primary-hepatocytes-market.asp

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.